Alpha-Synuclein in Parkinson’s Disease: From Pathogenetic Dysfunction to Potential Clinical Application
Open Access
- 1 January 2016
- journal article
- review article
- Published by Wiley in Parkinson's Disease
- Vol. 2016, 1-10
Abstract
Parkinson’s disease is a neurodegenerative disease/synucleinopathy that develops slowly; however, there is no efficient method of early diagnosis, nor is there a cure. Progressive dopaminergic neuronal cell loss in the substantia nigra pars compacta and widespread aggregation of theα-synuclein protein (encoded by theSNCAgene) in the form of Lewy bodies and Lewy neurites are the neuropathological hallmarks of Parkinson’s disease. TheSNCAgene has undergone gene duplications, triplications, and point mutations. However, the specific mechanism ofα-synuclein in Parkinson’s disease remains obscure. Recent research showed that variousα-synuclein oligomers, pathological aggregation, and propagation appear to be harmful in certain areas in Parkinson’s disease patients. This review summarizes our current knowledge of the pathogenetic dysfunction ofα-synuclein associated with Parkinson’s disease and highlights current approaches that seek to develop this protein as a possible diagnostic biomarker and therapeutic target.Keywords
Funding Information
- National Natural Science Foundation of China (81400933, 2016KYB119)
- Zhejiang Medical Science and Technology Plan Project (81400933, 2016KYB119)
This publication has 97 references indexed in Scilit:
- Skin nerve misfolded α‐synuclein in pure autonomic failure and Parkinson diseaseAnnals of Neurology, 2015
- Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategiesExperimental & Molecular Medicine, 2015
- Pharmacological Treatment of Parkinson DiseaseJAMA, 2014
- Submandibular gland needle biopsy for the diagnosis of Parkinson diseaseNeurology, 2014
- Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trialsActa Neuropathologica, 2014
- α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregationNature, 2011
- α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in VitroScience, 2010
- Structure and Dynamics of Micelle-bound Human α-SynucleinJournal of Biological Chemistry, 2005
- Impact of the Acidic C-Terminal Region Comprising Amino Acids 109−140 on α-Synuclein Aggregation in VitroBiochemistry, 2004
- Identification of two distinct synucleins from human brainFEBS Letters, 1994